Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities

Brain Research Bulletin

Volumn 55, Issue 2, 2001, Pages 319-325

  Van Rensburg, S J ^a   Potocnik, F C V ^a   Kiss, T ^b   Hugo, F ^a   Van Zijl, P ^a   Mansvelt, E ^a   Carstens, M E ^a   Theodorou, P ^c   Hurly, P R ^d   Emsley, R A ^a   Taljaard, J J F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF SZEGED   (Hungary)

^c National Centre for Occupational Health   (South Africa)

^d C51 Edingight   (South Africa)

Author keywords

Aluminum; Cholesterol; Chronic fatigue; Cognition; DHEAS; Iron

Indexed keywords

ALUMINUM; HEMOGLOBIN; HYDROCORTISONE; PRASTERONE SULFATE;

CHOLESTEROL BLOOD LEVEL; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED STUDY; COPPER BLOOD LEVEL; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; IRON BLOOD LEVEL; MALE; PRIORITY JOURNAL; STEROID BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL;

ADULT; ALUMINUM; BINDING, COMPETITIVE; CHOLESTEROL; COGNITION DISORDERS; COPPER; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; FATIGUE SYNDROME, CHRONIC; FEMALE; FERRITINS; GENE FREQUENCY; HEMOGLOBINS; HUMANS; HYDROCORTISONE; IRON; MALE; METALS; SEX FACTORS; STEROIDS; TRANSFERRIN; ZINC;

EID: 0035872460     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00478-6     Document Type: Conference Paper

References (46)

1. Aluminum intoxication
2. Oxidants from phagocytes: Agents of defense and destruction
3. Clinical guidelines: Chronic fatigue syndrome
4. Clinical laboratory test findings in patients with chronic fatigue syndrome
5. One person's view of iron deficiency, development, and cognitive function
6. Transferrin C2 as an enhancer of cyto- and genotoxic damage
7. Proceedings of a workshop: Impact of infection on nutritional status of the host
8. Iron therapy in chronically fatigued, nonanemic women: A double-blind study
9. Anaemia and iron deficiency in athletes. Practical recommendations for treatment
10. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome
11. Symptom patterns in long-duration chronic fatigue syndrome
12. DHEA administration increases rapid eye movement sleep and EEG power in the sigma frequency range
13. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome
14. Aluminium salts accelerate peroxidation of membrane lipids stimulated by iron salts
15. Stress and the hypothalamo-pituitary-adrenal axis: Acute, chronic and immunological activation
16. Binding and transport of aluminium by serum proteins
17. Equilibrium constants for the binding of aluminium to human serum transferrin
18. Speciation of aluminium in biological systems
19. Biosynthesis of DHEAS by the human adrenal cortex and its age-related decline
20. Clinical import of small increases in serum aluminum
21. Effect of body iron stores on serum aluminium level in hemodialysis patients
22. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome
23. Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome
24. Incomplete occlusion of central retinal artery in a girl with iron deficiency anemia
25. Activation of CD4+ and CD8+ T-lymphocytes in bone marrow associated with reduced erythropoiesis in patients with chronic inflammation and anaemia
26. Iron deficiency and cognitive function
27. Zinc and platelet membrane microviscosity in Alzheimer's disease. The in vivo effect of zinc on platelet membranes and cognition
28. Dehydroepiandrosterone (DHEA) - The "Mother Steroid". I. Immunologic action
29. Dehydroepiandrosterone (DHEA) - The multifunctional steroid. II. Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action?
30. Free radicals in chronic fatigue syndrome: Cause or effect?
31. Effects of dehydroepiandrosterone and its sulfate on brain tissue in culture and on memory in mice
32. Paresteziia slizistoi obolochki polosti rta, obuslovlennaia defitsitom zheleza
33. Chronic fatigue syndrome research
34. Inhibition of protein isoprenylation and p21ras membrane association by dehydroepiandrosterone in human colonic adenocarcinoma cells in vitro
35. SPECT imaging of the brain: Comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression
36. Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health
37. Trace elements and inflammatory response: Implications for nutritional support
38. Rationalisation of metal binding to transferrin: Prediction of metal-protein stability constants
39. Reduced plasma dehydroepiandrosterone concentrations in Alzheimer's disease
40. Increased frequency of the transferrin C2 subtype in Alzheimer's disease
41. A new model for the pathophysiology of Alzheimer's disease: Aluminium toxicity is exacerbated by hydrogen peroxide and attenuated by an amyloid protein fragment and melatonin
42. A comparative study of the effects of cholesterol, beta-sitosterol, beta-sitosterol glycoside, dehydroepiandrosterone sulphate and melatonin on in vitro lipid peroxidation
43. Optic disc swelling in Crohn's disease
44. 2+ antagonize NMDA and GABA responses of hippocampal neurons